Determination of the additional clinical value of contrast enhanced ultrasound imaging for the diagnosis of prostate cancer

Completed

• Conditions: prostate cancer; prostate carcinoma; 10038364

• Registration Number: NL-OMON29721
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2016-12-01
• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 250

Inclusion Criteria

Biopsy proven prostate carcinoma, treatment by (laparoscopic) radical prostatectomy

Exclusion Criteria

severe cardiac problems, severe hypertension

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Parameters of contrast enhanced ultrasound will be correlated and compared to<br /><br>the histology of the resected prostate. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Adverse events of the used contrast agent</p><br>